Clinical trialNCT06346015UnknownInterventional

Gamma Entrainment Stimulation for Cognitive Dysfunction After aSAH

SponsorBeijing Tiantan HospitalEnrollment60Cognitive DysfunctionSubarachnoid Hemorrhage, Aneurysmal

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to Explore and verify whether 40Hz audio and binaural beat 40Hz audio can improve the postoperative cognitive dysfunction seen in patients with aneurysmal subarachnoid hemorrhage. This study is a single-center, prospective, randomized, controlled clinical trial. Patients with aneurysmal subarachnoid hemorrhage were selected and randomized into intervention group (audio adjuvant group) and control group (conventional treatment group). Patients in the intervention group will receive audio therapy after surgery, and patients in the control group will receive usual care. EEG, fMRI and mRS scores were evaluated after 3 months of follow-up.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Cunyang Li, MD
Beijing Tiantan Hospital
Study Director
clinicaltrials.gov ↗
Guangzhi Shi, MD
Beijing Tiantan Hospital
Study Director
clinicaltrials.gov ↗
Jun Yang, MD
Beijing Tiantan Hospital
Study Director
clinicaltrials.gov ↗
Junwei Lv, MD
Shanghai Joyingmed Sensory Stimulation Lab
Study Director
clinicaltrials.gov ↗
Ke Wang, MD
Beijing Tiantan Hospital
Study Director
clinicaltrials.gov ↗
Nianze Chen, MD
Shanghai Joyingmed Sensory Stimulation Lab
Study Director
clinicaltrials.gov ↗
Yu Chen, MD
Beijing Tiantan Hospital
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Apr 2024
Primary completion: 31 Mar 2025
Completion: 31 Mar 2025
Last update posted: 3 Apr 2024
Registered enrollment: 60
Registry id: NCT06346015

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.